Prokidney (PROK) Liabilities and Shareholders Equity (2021 - 2026)

Prokidney (PROK) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $292.8 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 27.9% year-over-year to $292.8 million in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 25.75% decrease from a year earlier, with the FY2025 full-year figure at $335.6 million, down 23.92% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $292.8 million, down from $335.6 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for PROK reached as high as $532.4 million in Q3 2022 and fell as low as $250.8 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $409.7 million across 5 years, with a median of $420.6 million in 2023.
• Across the five-year window, Liabilities and Shareholders Equity jumped 40202.15% in 2022 and decreased 27.9% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $518.0 million in 2022, then declined by 18.81% to $420.6 million in 2023, then increased by 4.88% to $441.1 million in 2024, then declined by 23.92% to $335.6 million in 2025, then slipped by 12.75% to $292.8 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $292.8 million in Q1 2026, $335.6 million in Q4 2025, and $351.6 million in Q3 2025.